Association between the Frequency of Daily Toothbrushing and Development of Nonalcoholic Fatty Liver Disease.

Metabolic syndrome Nonalcoholic fatty liver disease Periodontal disease Porphyromonas gingivalis Toothbrushing

Journal

Digestive diseases (Basel, Switzerland)
ISSN: 1421-9875
Titre abrégé: Dig Dis
Pays: Switzerland
ID NLM: 8701186

Informations de publication

Date de publication:
2021
Historique:
received: 23 09 2020
accepted: 22 01 2021
pubmed: 4 2 2021
medline: 26 11 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

Background & Aim: This study aimed to evaluate the association between the frequency of daily toothbrushing and the development of nonalcoholic fatty liver disease (NAFLD). A retrospective longitudinal study was conducted from 2005 to 2012 at the Center for Preventive Medicine at St. Luke's International Hospital, Japan. Data on all participants who underwent a health checkup during the study period were collected. NAFLD was diagnosed by abdominal ultrasonography, and all participants who were diagnosed with NAFLD at the time of their initial visit, consumed alcohol in any amount, or had received only one health checkup were excluded. The questionnaire for the frequency of daily toothbrushing was conducted as part of health checkups. The primary outcome was the risk of developing NAFLD according to the frequency of daily toothbrushing (1-2 times a day or 3 times a day) compared to those who brush teeth once or less than once a day. Data were collected from 25,804 people. A total of 3,289 (12.7%) participants developed NAFLD. The mean age was 45.2 years, and 6,901 (26.7%) of the participants were male. The risk of developing NAFLD significantly decreased with increased frequency of daily toothbrushing. Adjusted odds ratios (ORs) are as follows: brushing teeth 1-2 times a day (OR: 0.85, 95% confidence interval [CI]: 0.77-0.95) and 3 times a day (OR: 0.74, 95% CI: 0.67-0.82). Frequent toothbrushing was shown to significantly reduce the risk of developing NAFLD.

Identifiants

pubmed: 33535206
pii: 000514930
doi: 10.1159/000514930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

646-652

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Kazuki Yamamoto (K)

Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.

Takashi Ikeya (T)

Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.

Shuhei Okuyama (S)

Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.

Katsuyuki Fukuda (K)

Department of Gastroenterology, St. Luke's International Hospital, Tokyo, Japan.

Daiki Kobayashi (D)

Department of Medicine, St. Luke's International Hospital, Tokyo, Japan.
Department of Epidemiology, St. Luke's Graduate School of Public Health, Tokyo, Japan.
Department of Medicine, Fujita Health University, Toyoake, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH